Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors?
Author:
- 1 November 1991
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 42 (12) , 2253-2258
Abstract
No abstract availableFunding Information
- Thomas F. and Kate Miller Jeffress Memorial Trust
This publication has 40 references indexed in Scilit:
- Uncoupling the DNA cleavage and religation activities of topoisomerase II with a single-stranded nucleic acid substrate: evidence for an active enzyme-cleaved DNA intermediateBiochemistry, 1990
- Sequence-selective topoisomerase II inhibition by anthracycline derivatives in SV40 DNA: relationship with DNA binding affinity and cytotoxicityBiochemistry, 1990
- Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposideBiochemistry, 1989
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Further Characterization of Drug-Sensitivity and Cross-Resistance Profiles of Cloned Cell Lines of Adriamycin®-Sensitive and -Resistant P388 LeukemiaCancer Communications, 1989
- DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombeCell, 1987
- Recent studies of DNA topoisomerasesBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1987
- Topoisomerase II is a structural component of mitotic chromosome scaffolds.Journal of Cell Biology, 1985
- Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase IIScience, 1984
- DNA double-strand breaks in mammalian cells after exposure to intercalating agentsBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1981